Novartis Ag (NVS) EBT (2009 - 2026)
Novartis Ag (NVS) recorded EBT of $4.27 billion in Q2 2026, down 5.8% from $4.53 billion a year earlier but up 11.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) EBT (2009 - 2026) Analysis & Trends
On a TTM basis, Novartis Ag's EBT came in at $15.52 billion as of Jun 30, 2026, down 0.6% year-over-year; for FY2025, it was $16.35 billion, up 19.9% from FY2024.
- Annual EBT has increased for three straight years, with a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
- Across earlier years, EBT came in at $13.64 billion in FY2024 (+49.5%), $9.12 billion in FY2023 (+27.1%), $7.18 billion in FY2022 (-70.7%) and $24.53 billion in FY2021 (+148.3%).
- Quarterly EBT has ranged from $1.74 billion in Q4 2022 to $16.95 billion in Q4 2021 over the past five years.
- On a year-over-year basis, EBT has declined for three consecutive quarters, with growth averaging 18.8% over the last eight quarters.
- Peak year-over-year performance for EBT in the last five years was growth of 562.4% in Q4 2021, against a decline of 89.7% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.84 billion (Q1 2026), $3.22 billion (Q4 2025) and $4.2 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn | 1.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Bn |
| Mar 31, 2026 | 3.84 Bn |
| Dec 31, 2025 | 3.22 Bn |
| Sep 30, 2025 | 4.20 Bn |
| Jun 30, 2025 | 4.53 Bn |
| Mar 31, 2025 | 4.41 Bn |
| Dec 31, 2024 | 3.29 Bn |
| Sep 30, 2024 | 3.39 Bn |
| Jun 30, 2024 | 3.84 Bn |
| Mar 31, 2024 | 3.13 Bn |
| Dec 31, 2023 | 2.38 Bn |
| Sep 30, 2023 | 1.55 Bn |
| Jun 30, 2023 | 2.67 Bn |
| Mar 31, 2023 | 2.52 Bn |
| Dec 31, 2022 | 1.57 Bn |
| Sep 30, 2022 | 1.59 Bn |
| Jun 30, 2022 | 2.04 Bn |
| Mar 31, 2022 | 2.67 Bn |
| Dec 31, 2021 | 16.95 Bn |
| Sep 30, 2021 | 3.23 Bn |
API Access
Novartis Ag EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();